Power of Liquid Biopsy Tracking in Immunotherapy Treated Stage IV Melanoma
NCT06710093
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Melanoma
Sponsor
Royal Marsden NHS Foundation Trust